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Parental imprinting results in monoallelic parent-of-
origin-dependent gene expression. However, many
imprinted genes identified by differential methylation
do not exhibit complete monoallelic expression. Pre-
vious studies demonstrated complex tissue-depen-
dent expression patterns for some imprinted genes.
Still, the complete magnitude of this phenomenon
remains largely unknown. By differentiating human
parthenogenetic induced pluripotent stem cells into
different cell types and combining DNA methylation
with a 50 RNA sequencing methodology, we were
able to identify tissue- and isoform-dependent im-
printed genes in a genome-widemanner.We demon-
strate that nearly half of all imprinted genes express
both biallelic and monoallelic isoforms that are
controlled by tissue-specific alternative promoters.
This study provides a global analysis of tissue-spe-
cific imprinting in humans and suggests that alter-
native promoters are central in the regulation of
imprinted genes.
INTRODUCTION
Parental imprinting involves a subset of genes that is expressed
exclusively from only one of the parental alleles. One of the hall-
marks of this phenomenon is considered to be the preclusion of
asexual forms of reproduction in placental mammals. This was
manifested by the inability of complete maternal (parthenoge-
netic) and paternal (androgenetic) mouse embryos to develop
normally and survive to term (McGrath and Solter, 1984; Surani
and Barton, 1983; Surani et al., 1986). It is estimated that roughly
100 genes are imprinted in both human and mouse, many of
which are expressed in the placenta and the brain (Coan et al.,
2005; Davies et al., 2005; Fowden et al., 2006; Wilkinson et al.,308 Cell Reports 11, 308–320, April 14, 2015 ª2015 The Authors2007). Intriguingly, chimericmicemodels suggest that in addition
to their role in early development, imprinted genes are subjected
to a complex tissue-specific expression in the developing em-
bryo (Thomson and Solter, 1988; Wilkinson et al., 2007). Specif-
ically, a highly complex spatial distribution of imprinted genes
was observed in the brain (Davies et al., 2005), making it a useful
tissue in the study of parental imprinting. In humans, because of
limited accessibility to study material, little is known about the
magnitude of tissue-specific imprinted genes expression.
One major limitation in studying tissue-specific expression of
imprinted genes is the requirement to analyze a homogenous
population of cells at a specific developmental stage. Partheno-
genetic pluripotent stem cells (PSCs) serve as an attractive tool
to study the role of imprinted genes in early embryonic develop-
ment because they completely lack their paternal alleles. Both
parthenogenetic and normal biparental PSCs can be differenti-
ated into specific cell types, allowing for a comprehensive
comparison of gene expression in a tissue-specific manner.
We have previously shown that parthenogenetic induced PSCs
(Pg-iPSCs) can be generated successfully by reprogramming
of parthenogenetic ovarian teratomas (Stelzer et al., 2011).
Genome-wide gene expression and DNA methylation analyses
confirmed the parthenogenetic origin of these cells and enabled
the identification of additional paternally expressed genes
(PEGs) and imprinted differentially methylated regions (iDMRs)
throughout the human genome (Stelzer et al., 2011, 2013).
Furthermore, differentiating the Pg-iPSCs both in vivo and
in vitro identified marked effects on the extra-embryonic
trophectoderm and on embryonic liver and muscle tissues.
These results demonstrated that Pg-iPSCs may be utilized to
study tissue-specific effects of imprinted genes in early human
development.
Here we conducted a genome-wide tissue-specific study of
imprinted genes in humans. Our analyses uncovered additional
candidate imprinted genes that are differentially expressed
between normal and parthenogenetic differentiated cells and
expressed in a monoallelic fashion in normal cells. In addition,
analyzing high-throughput sequencing data of both gene
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expression and DNA methylation suggests that nearly half of
the previously identified PEGs are subjected to a complex iso-
form and tissue-dependent regulation, which is controlled by
iDMRs that reside at alternative promoters. Finally, as these
complex tissue-specific isoforms are not easily detected using
current methods, we developed a technique that enables
a genome-wide search for tissue and isoform dependent im-
printed genes.
RESULTS
Differentiation of Parthenogenetic and Normal PSCs to
Different Cell Types
To analyze the expression of human imprinted genes in various
embryonic lineages, we differentiated normal PSCs and Pg-
iPSCs into neural progenitor cells (NPCs) (Kim et al., 2010), as
well as into early endodermal cells (Kopper and Benvenisty,
2012) (Figures 1A–1C). Amajor roadblock for enabling a compre-
hensive tissue-specific analysis of parental imprinting is the
inherent heterogeneity in the differentiated cell populations. To
overcome this limitation, we used surface markers for sorting
the cells in order to generate more homogeneous cell popula-
tions (Figures 1A–1E). We used NCAM1 as a marker for NPCs
and CXCR4 as a marker for early endoderm progenitor cells
(Kopper and Benvenisty, 2012) (Figures 1D and 1E). Analyzing
the gene expression of both positive and negative sorted cells
populations confirmed their ectodermal and endodermal identity
(Figures S1A and S1B, respectively). As expected, both
NCAM1+ and CXCR4+ cell populations downregulated pluripo-
tency associated markers and upregulated characteristic tissue-
specific genes (Figure S1). In addition, comparing the gene
expression profiles of the sorted cells populations and their
parental undifferentiated cells demonstrated marked differences
between their overall gene expression patterns (Figure 1F). Next,
we compared the gene expression of the parthenogenetic and
control cells for both NCAM1+ and CXCR4+ populations. This
analysis identified a high correlation between the parthenoge-
netic and control cells, indicative of successful and robust
differentiation (Figure 1G). In spite of this general similarity, close
examination revealed some of the known PEGs to be downregu-
lated in the parthenogenetic cells as compared with control cells
(Figure 1G). Maternally expressed genes (MEGs) are less easily
detected using parthenogenetic cells, as they are expected to
exhibit a merely 2-fold increase in their gene expression as
compared with normal cells. Therefore, we focused our analysisFigure 1. Differentiation of Human Pg-iPSCs into Different Cell Types
(A) Schematic illustration of the experimental design.
(B and C) Schematic diagrams illustrating the protocols that were used to different
embryoid body.
(D) Following 10 days of neural differentiation, cells were sorted using NCAM1. S
NCAM1-positive population (29% ± 4.5%).
(E) Following 7 days of endodermal differentiation, cells were sorted using CXCR4.
CXCR4-positive population (53% ± 15.4%).
(F) Scatterplot analysis demonstrating differences in expression signature betwe
differentiation. (Lower) Endodermal progenitor cells.
(G) Scatterplot analysis of global gene expression comparing the parthenogenet
cells (lower). Values are displayed on a logarithmic scale. Labeled genes set as exa
variants of SNORD116.
310 Cell Reports 11, 308–320, April 14, 2015 ª2015 The Authorson studying tissue-dependent PEGs in both NCAM1+ and
CXCR4+ sorted cell populations.
Charting the Dynamics of Known PEGs during Early
Human Differentiation
Analyzing known PEGs in the three different cell types (e.g., PSC,
NCAM1+, CXCR4+) enabled us to classify the expressed PEGs
according to two distinct expression patterns: (1) known PEGs
that are consistently downregulated in the parthenogenetic cells
as compared with control cells and (2) PEGs that are highly ex-
pressed in the parthenogenetic cells at comparable levels with
the control cells, in at least one examined cell type (Figure 2A).
Notably, unlike in group I, in which known PEGs showed consis-
tent downregulation in all parthenogenetic cell types (e.g.,
PEG10; Figure 2B), some genes in group II showed high and
comparable expression levels between the parthenogenetic
and control cells in all cell types examined (e.g., GNAS; Fig-
ure 2B). Other genes in group II exhibited a more complex
expression signature with high expression levels in some cell
types and complete downregulation in others (e.g., MEST; Fig-
ure 2B). Accordingly, we sought to study the different genomic
and epigenomic characteristics of the two groups of PEGs. Inter-
estingly, close examination of annotated transcripts (RefSeq
and USCS genes) of PEGs that showed consistent downregu-
lation in the parthenogenetic cells (group I) revealed that the
vast majority are single isoform genes (Figure 2C). In contrast,
PEGs that showed high or variable expression levels in the
parthenogenetic cells (group II) tended to exhibit a complex
genomic organization consisting ofmultiple isoforms (Figure 2D).
The parent-of-origin-specific marks are established in the
germ cells by differential DNA methylation (Reik et al., 2001;
Sasaki and Matsui, 2008). Unlike gene expression, which is
tissue dependent and regulated by cell-specific transcription
factors, iDMRs aremaintained inmost tissues to allow themono-
allelic parent-of-origin expression of imprinted genes. Recently,
a high-resolution single-base DNA methylation sequencing in
multiple undifferentiated and adult tissues was reported (Bern-
stein et al., 2010). We therefore applied these data to link be-
tween gene expression of known PEGs and the genomic organi-
zation of their iDMRs. Normal post-zygotic tissues should exhibit
intermediate methylation levels (30%–70% methylated CpGs)
in their iDMRs. We also utilized a complete sperm methylome
(Bernstein et al., 2010; Molaro et al., 2011), which should appear
either hypermethylated (>70%methylated CpGs) or hypomethy-
lated (<30% methylated CpGs) in iDMRs as compared with theiate the different PSC types to (B) NPCs or (C) endodermal progenitor cells. EB,
hown is a representative PSC line. G1, sorted negative population. G2, sorted
Shown is a representative PSC line. G2, sorted negative population. G1, sorted
en representative PSC lines and their differentiated derivatives. (Upper) NPCs
ic and normal cells in NPCs differentiation (upper) and endodermal progenitor
mples of known PEGs (blue lines). Multiple points cluster representing different
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post-zygotic tissues. Known PEGs that displayed consistent
downregulation in the different parthenogenetic cell types (e.g.,
group I; Figure 2A) were either regulated in clusters by an inter-
genic germline-derived iDMRs (e.g., DLK1-DIO3 region) or by
germline or secondary iDMRs that reside in the gene’s promoter
region (e.g., PEG10; Figure 2C). Alternatively, known PEGs that
show high or variable expression levels in the parthenogenetic
cells (e.g., group II; Figure 2A) exhibited an iDMR at alternative
promoters (e.g., MEST; Figure 2D). The existence of an iDMR
at alternative promoters was previously suggested to regulate
the isoform-specific monoallelic expression of MEST, GRB10,
INPP5F, and GNAS (Hikichi et al., 2003; Kamei et al., 2007; Liu
et al., 2005; Wood et al., 2007). Our analysis shows that nearly
half of the known PEGs include alternative promoters (Table
S1), suggesting the co-existence of a biallelic isoform along
with the imprintedmonoallelic isoform. Simultaneous expression
of an overlapping biallelic and monoallelic transcripts might
explain the high levels of expression observed in the parthenoge-
netic cells. To test this notion, we separated all known PEGs
into two groups: genes consisting of only a single isoform and
genes with alternative promoters (Table S1); we examined the
relative expression between parthenogenetic and control cells
in each group. Remarkably, this separation completely distin-
guished the PEGs that were consistently downregulated in the
parthenogenetic cells (i.e., group I) from those that were either
highly expressed or showed variable expression levels in the
parthenogenetic cells (i.e., group II) (Figures 2E and 2F). Notable
exceptions were SNRPN and IGF2, which are consistently
downregulated in the parthenogenetic cells but exhibit several
isoforms. Nevertheless, unlike other PEGs with alternative pro-
moters, each of the isoform specific promoters of SNRPN and
IGF2 comprises a secondary iDMR that regulates their monoal-
lelic expression (Vu and Hoffman, 1994). Another exception is
DLK1, which is a single isoform PEG that exhibits high expres-
sion levels in the differentiated parthenogenetic cells (Figure 2E).
Interestingly, the overexpression of DLK1 is in agreement with
previous report on its biallelic expression in specific regions of
themouse brain (Ferro´n et al., 2011). Therefore, our data suggest
that the human DLK1 is expressed in a biallelic fashion after
implantation, similar to the observations in mouse.
Analysis of Isoform- and Tissue-Specific Expression in
Known PEGs
Next, we sought to validate isoform-specific imprinting of known
PEGs. Analyzing the expression of MEST in the three differentFigure 2. Charting the Dynamics of Known PEGs throughout Different
(A) Distribution of expression ratios for all expressed PEGs (n = 56) in the three diff
parthenogenetic (Pg) cells, and y axis represents the distribution of frequencies
increase in expression ratio and was used to classify the known PEGs according
(B) Average expression levels ± SD comparing the parthenogenetic and control
(C and D) Regional view of two representative group I and group II PEGs (PEG10
0 (non-methylated). Shown are average methylation levels of different cell types w
bright blue. Note the schematic setting of the monoallelic (mono)- and biallelic (b
(E) Distribution of expression ratios in the three different tissues for single isoform
represent the log2-fold change between control (WT) and parthenogenetic (Pg)
samples; vertical segmented red lines represent a 3-fold increase in expression
(F) Expression patterns ofMEST biallelic (bi) and monoallelic (mono) isoforms as
PSC lines; band sizes are designated in bp.
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in PSCs but is downregulated in NCAM1+ and CXCR4+ cells
(Figure 2B). To identify whether the short imprinted isoform is
also expressed in PSCs, we designed specific primers that
allows discrimination between the two isoforms (Figure 2D). Per-
forming RT-PCR on the Pg-iPSCs and normal PSCs confirmed
the expression of the imprinted isoform, as it is completely
downregulated in the Pg-iPSCs as compared with normal
PSCs (Figure 2F). In addition to utilizing parthenogenetic (Stelzer
et al., 2011) and uniparental disomy cells (Nakabayashi et al.,
2011), previous studies implemented allelic expression on pedi-
grees (Ge et al., 2009; Morcos et al., 2011; Pollard et al., 2008) to
map globally parent-of-origin monoallelic expression in the
human genome. However, this approach is also limited in identi-
fying imprinted genes that exhibit multiple isoforms. Thus, simul-
taneous expression of overlapping imprinted and non-imprinted
transcripts should result in parental bias rather than complete
monoallelic expression. To confirm the parental bias in specific
isoforms, we utilized a previously reported allelic expression
analysis on lymphoblastoid cell lines (LCLs) derived from seven
individuals from CEPH 1,420 pedigree (Ge et al., 2009; Morcos
et al., 2011). We studied the isoform- and tissue-dependent
expression of known PEGs, which were not previously shown
to be regulated by an alternative promoter. L3MBTL1 is a known
PEG that encodes a member of the polycomb family of proteins
(Li et al., 2004). Nevertheless, although its functional role was
thoroughly studied, the parent-of-origin regulation of L3MBTL1
is still largely unknown. Studying its genomic and epigenomic
properties suggests that L3MBTL1 is subjected to regulation
by two alternative promoters (Figure S2A). The downstream
promoter is marked with a maternally derived iDMR, whereas
the upstream promoter consists of hypomethylated CpG
Island (Figure S2A). We therefore designed specific primers to
distinguish between the different isoforms and studied their
expression in different parthenogenetic and control cell types.
Our results show that the L3MBTL1 isoform that originates
from its upstream promoter was expressed in both parthenoge-
netic and control cells, whereas the isoform that originates from
the downstream promoter was completely downregulated in the
parthenogenetic cells (Figure S2B). The overlap between the
different isoforms of L3MBTL1 also explains why the imprinted
transcript exhibits parental bias instead of complete monoallelic
expression, as shown by parent-of-origin allelic expression
(Figure S2A). In addition, the existence of biallelic and monoal-
lelic overlapping transcripts may underline previous reportsiation
erent tissues; x axis represents the log2-fold change between control (WT) and
for each of the samples; the vertical segmented red line represents a 3-fold
to two distinct groups.
cells in the different cells types for three representative PEGs.
and MEST, respectively). DNA methylation varies from 1 (fully methylated) to
ith respect to the genomic organization of the genes. iDMRs are highlighted in
i)-specific primer sets used to specifically identify MEST isoforms.
PEGs (n = 39, left) and PEGs with multiple isoforms (n = 17, right). The x axes
cells, and the y axes represent the distribution of frequencies for each of the
ratio.
measured by RT-PCR in representative control (WT) and parthenogenetic (Pg)
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indicating that themouse ortholog of L3MBTL1 escapes parental
imprinting (Li et al., 2005).
Utilizing our genome-wide DNA methylation analysis on
the Pg-iPSCs, we previously confirmed the presence of a
maternal-derived iDMR at the promoter of ZNF331 (Stelzer
et al., 2013). Nevertheless, comparing the gene expression of
ZNF331 between normal and parthenogenetic PSCs exhibited
comparable high expression levels. In addition, previous studies
reported conflicting data regarding the imprinting of ZNF331,
identifying monoallelic expression in some tissues and biallelic
expression in others (Pant et al., 2006; Pollard et al., 2008).
Similar to other known PEGs, ZNF331 is regulated by two pro-
moters marked by H3K4me3 chromatin modification (Figure 3A).
The downstream promoter consists of a maternal-derived iDMR,
whereas the upstream promoter harbors a hypomethylated CpG
island (Figure 3A). Following previous reports of monoallelic
expression of ZNF331 in the placenta (Noguer-Dance et al.,
2010), we analyzed trophectoderm-like cells derived from Pg-
iPSCs and normal PSCs (Stelzer et al., 2011), which confirmed
the co-expression of both biallelic and monoallelic isoforms of
ZNF331 (Figure 3B). Two distinct isoforms originating from a pro-
moter residing in an iDMR were downregulated in the partheno-
genetic cells in both NCAM1+ cells and trophectoderm-like cells,
but were not expressed in either control or parthenogenetic
PSCs (Figure 3B). In contrast, the long isoform, which originates
from the unmethylated upstream promoter, was expressed in all
parthenogenetic and control cell types (Figure 3B). In addition to
validation using the parthenogenetic cells, we also implemented
the parent-of-origin allelic expression analysis in LCLs. These
results are in agreement with the predicted isoform-specific
imprinting of ZNF331 as the non-overlapping transcribed region
of the upstream isoform exhibited full biallelic expression. How-
ever, the region that included the overlap between the different
isoforms displayed profound parental bias (Figure 3A). Taken
together, our analysis of known PEGs demonstrated that many
of these imprinted genes are associated with complex tissue-
and isoform-specific expression, which may explain some of
the conflicting reports regarding their parent-of-origin regulation.
Genome-wide Search for Tissue-Specific
Imprinted Genes
To identify additional imprinted genes, we focused on genes that
are markedly downregulated (>3-fold) in both NCAM1+ and
CXCR4+ parthenogenetic cells as compared with control cells
(i.e., genes from group I; Figure 2A). Among the PEGs resulting
in this analysis, we further analyzed two putative PEGs that are
downregulated in a significant manner (p % 0.05) (Figure 3C).
The two candidate genes, NAIP and WDR17, were not
expressed in the undifferentiated cells (Figure S3A) and
therefore could not have been detected in our previous analysismaternal parental bias, respectively; black arrows point at biallelic expressed
monoallelic (mono)- and biallelic (bi)-specific primer sets used to specifically ide
(B) Expression patterns of ZNF331 across different tissues of both biallelic and m
parthenogenetic (Pg) cell lines. TE, trophectoderm. Band sizes are designated in
(C) Average expression levels ± SD of two candidate PEGs in control and parthe
(D) Sequencing ofNAIP andWDR17 in two independent control PSC line. Shown a
in the complimentary DNA (cDNA).
314 Cell Reports 11, 308–320, April 14, 2015 ª2015 The Authors(Stelzer et al., 2011). To verify whether the candidate PEGs
are expressed in a monoallelic fashion, we utilized informative
single nucleotides polymorphism (SNP), located in the tran-
scribed region of both NAIP and WDR17. By applying RT-PCR
and direct sequencing on two independent control sorted cells,
we validated the monoallelic expression of both genes (Fig-
ure 3D), indicating that they are indeed new PEGs.
Genome-wide Search for iDMRs in Genes with
Alternative Promoters
Next, we searched globally for imprinted genes that are regu-
lated by alternative promoters (i.e., group II genes; Figure 2A).
We therefore utilized single-base resolution DNA methylation
data (Bernstein et al., 2010; Molaro et al., 2011) and performed
an unbiased genome-wide search for iDMRs within genes that
comprise alternative promoters. To reduce the potential tissue-
specific variation and to increase the confidence of our findings,
we included different cell types in our analysis (see Supplemental
Experimental Procedures). The use of distinct cell types derived
fromdifferent individuals significantly minimized the possibility of
including DMRs that resulted from random monoallelic methyl-
ation rather than parental imprinting. We analyzed two adult
tissues, representative of ectodermal and endodermal lineages
(brain hippocampus and liver, respectively); PSC derived NPCs
that closely resemble our established NCAM1+ cells and two
undifferentiated PSCs (H1 and H9 cell lines). In addition, to
identify the parent-of-origin signature of the putative iDMRs,
we included testis spermatozoa primary cells (Bernstein et al.,
2010; Molaro et al., 2011). The analysis comprised the subgroup
of autosomal genes in the human genome, which harbor alter-
native promoters, including 1-kb regions both upstream and
downstream to these genes. Subsequently, we searched for
regions with consistent intermediate methylation levels in all
samples. Then we further analyzed the levels of DNAmethylation
in primary testis cells and included regions that were either
hypermethylated or hypomethylated in the testis (see Supple-
mental Experimental Procedures). Taken together, this analysis
validated the majority (13 of 18) of the known PEGs with iDMRs
at alternative promoters (Table S2). Notable exceptions
were IGF2 and INS-IGF2, which did not include consistent
iDMRs between the samples. SLC22A18 and TSC22D1, which
comprise relatively small iDMR and therefore did not pass our
threshold (see Supplemental Experimental Procedures), and
NTM for which we could not detect an iDMR. In addition to 13
known imprinted genes, we identified 28 putative candidate
genes with alternative promoters that harbor an intragenic
iDMR (Figure 4A; Table S2). To further link the genomic location
of the iDMRs to their putative regulatory function, we analyzed
the distances between the iDMRs with respect to the transcrip-
tion start site (TSS; Figure 4B). This analysis demonstrated thatSNPs. iDMR is highlighted in bright blue. Note the schematic setting of the
ntify ZNF331 isoforms.
onoallelic isoforms as measured by RT-PCR in representative control (WT) and
bp.
nogenetic cell types.
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the vast majority of putative iDMRs reside in close proximity to at
least one TSS of their associated gene. Nevertheless, as some
putative iDMRs are located relatively far from any known TSS,
we further analyzed the distance between the iDMRs and
the promoter-associated histone mark H3K4me3 (Figure 4C).
Interestingly, virtually all putative iDMRs were associated with
H3K4me3marks (Figure 4C), suggesting that additional isoforms
remain to be identified for some of these genes. Next we
checked whether the iDMRs that reside in genes with alternative
promoters are conserved among species. We thus utilized previ-
ously reported single-base resolution DNA methylation analysis
in both mouse (Stadler et al., 2011) and chimpanzee (Zeng
et al., 2012). In addition to searching for intermediatemethylation
levels in different cell types, we also verified that the appropriate
region contained either hypomethylation or hypermethylation
levels in mouse (Kobayashi et al., 2012) and chimpanzee (Molaro
et al., 2011) testis cells. Our results demonstrate that nearly half
of the iDMRs, which reside within genes with alternative pro-
moters, are conserved between human and mouse (Figure 4D;
Table S3). These results are in agreement with our previous anal-
ysis of all iDMRs in both mouse and human (Stelzer et al., 2013)
and at comparable conservation levels with the group of previ-
ously identified human iDMRs that are associated with alterna-
tive promoters (Figure S3B). Our analysis of the chimpanzee
methylome covers only 36 of the 46 human counterpart iDMRs
because of gaps in the current chimpanzee genomemap. Unlike
in the mouse, analyzing the chimpanzee methylome identified
high levels of conservation between the species (Figure 4D;
Table S3) and at comparable levels with the group of previously
identified iDMRs that are associated with alternative promoters
(Figure S3B). To further support our findings, we validated the
candidate isoform-dependent genes. As shown for substanti-
ated PEGs, DUSP22 is regulated by two promoters—an up-
stream promoter that harbors an iDMR and a downstream
promoter that is hypermethylated (Figure 4E). This epigenomic
setting suggests that DUSP22 consists of both a long monoal-
lelic isoform and a short biallelic isoform. Our global gene
expression analysis comparing parthenogenetic and control
cells could not detect differences in expression of DUSP22
(Figure 4F). However, by applying specific primers that were
able to distinguish the two isoforms, we could detect a complete
downregulation of the long isoform in two Pg-NCAM1+ cell lines
(Figure 4G), demonstrating thatDUSP22 is indeed a new isoform
dependent imprinted gene.
50 Transcript Sequencing for Confirmation of Imprinted
Genes with Alternative Promoters
Our analysis demonstrated that nearly 50% of the known
imprinted genes incorporate alternative promoters. As a result(B and C) Distribution of distances calculated from the putative iDMRs to the ne
Distances were normalized to gene length.
(D) Pie chart comparing the number of conserved iDMRs in alternative promoter
(E) Regional view of DUSP22. DNAmethylation varies from 1 (fully methylated) to 0
with respect to the genomic organization of the gene. iDMR is highlighted in brigh
specific primer sets used to specifically identify DUSP22 isoforms.
(F) Average expression levels ± SD of DUSP22 comparing between the partheno
(G) Expression patterns of the monoallelic and biallelic isoforms of DUSP22 in N
parthenogenetic (Pg) cell lines. Band sizes are designated in bp.
316 Cell Reports 11, 308–320, April 14, 2015 ª2015 The Authorsof the overlap between the imprinted and non-imprinted iso-
forms, only the promoter region of each isoform can exhibit
differential expression between the parthenogenetic and normal
cells. Therefore, we implemented a method that enables a
genome-wide expression analysis based on sequencing of the
50 end of the mRNA (see Supplemental Experimental Proce-
dures). RNA was extracted from NCAM1+ and PSC cell lines
from both parthenogenetic and control samples, and 50 cDNA
libraries were then generated. Sequencing of these libraries re-
sulted in identification of active promoters in both parthenoge-
netic and control cells. As a proof of concept, we compared
the 50 expression patterns of some known PEGs with alternative
promoters between the parthenogenetic and control cells. In
agreement with previous reports of isoform-specific imprinting
for the known PEGGRB10 (Monk et al., 2009), we demonstrated
the differential promoter expression between parthenogenetic
and control cells in only one out of the three promoters of this
gene (Figure S3C). Another example is the imprinted gene
GNAS, which was previously shown to exhibit a complex iso-
form- and tissue-dependent imprinting pattern (Kelsey, 2010).
Close examination of the complex genomic and epigenomic or-
ganization of the GNAS locus revealed five distinct promoters
that were marked by H3K4me3 chromatin modification:
NESP55, GNASAS, GNASXL, GNAS1A, GNAS1 (Figure 5A).
The allelic expression analysis revealed paternal bias of the iso-
forms that originated from theGNASAS andGNASXL promoters
and biallelic expression of the isoform that originated from the
GNAS1 promoter. The 50 RNA sequencing unraveled a more
convoluted expression pattern of these genes, supporting a
complex isoform-dependent parental expression. Some iso-
forms demonstrated paternal monoallelic expression (i.e., GNA-
SAS and GNAS1A), whereas others demonstrated maternal
(NESP55) or biallelic expression (GNAS1) (Figures 5A and 5B).
The 50 RNA sequencing analysis can enable the identification
of alternative promoters in genes that are known to have only a
single TSS. Therefore, we performed our DNA methylation anal-
ysis on single isoform genes and filtered the results to include
iDMRs located far from the known TSS, but next to K4me3 peaks
(Table S4). By combining the 50 RNA sequencing data with
the DNA methylation results, we validated another candidate
imprinted gene NHP2L1, which consists of two alternative pro-
moters: a known upstream promoter located in a hypomethy-
lated region with a high expression pattern in all cell types and
an additional downstream promoter located in an iDMR, which
displayed complete downregulation in the parthenogenetic cells
(Figures 5C and 5D). Thus, our results established that NHP2L1
includes an imprinted isoform. Finally, to conduct a genome-
wide search for additional PEGs with alternative promoters, we
compared the 50 RNA sequencing between parthenogeneticarest TSS (B) or to enrichment sites of histone mark H3K4me3 (p < 104) (C).
s between human and mouse (left) and human and chimpanzee (right).
(non-methylated); shown are average methylation levels of different cell types
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Figure 5. Utilizing a 50 RNA Sequencing Method to Identify Promoter-Specific Differential Expression
(A) Regional genomic and epigenomic view of the different isoforms ofGNAS. DNA methylation varies from 1 (fully methylated) to 0 (non-methylated); shown are
average methylation levels of different cell types with respect to the genomic organization of the different isoforms. Maternal-derived iDMRs are highlighted in
bright blue, while the secondary paternal iDMR is highlighted in bright red. Parent-of-origin-specific allelic expression was analyzed on LCLs derived from seven
individuals. Shown is the average parental bias of heterozygote SNP, calculated as the differences between b-values of gDNA and cDNA for each sample. Blue
and red are paternal or maternal parental bias, respectively; black arrows point at biallelic expressed SNPs. Normalized 50 reads for representative control and
parthenogenetic NCAM1+ cells are shown for each of the promoters.
(B) Expression analysis of the differentGNAS promoters quantifying the relative ratios ± SD of 50 reads between control and parthenogenetic cells. Black dashed
line represents similar expression levels.
(C) Regional genomic and epigenomic view of NHP2L1. DNA methylation varies from 1 (fully methylated) to 0 (non-methylated); shown are average methylation
levels of different cell typeswith respect to the genomic organization of the different isoforms. iDMR is highlighted in bright blue and associates with the H3K4me3
signature. Normalized 50 reads for representative control, and parthenogenetic NCAM1+ cells are shown for both the known upstream and the new downstream
promoters.
(D) Expression analysis of the different NHP2L1 promoters quantifying the relative ratios ± SD of 50 reads between control and parthenogenetic cells. Black
dashed line represents similar expression levels.
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AB
C
Figure 6. Tissue- and Isoform-Dependent
Imprinted Genes
(A–C) Concluding scheme depicting possible
expression patterns of tissue- and isoform-
dependent imprinted genes.
(A) Tissues that express both imprinted and non-
imprinted isoforms.
(B) Tissues inwhich only the non-imprinted biallelic
isoforms are expressed.
(C) Tissues in which only the imprinted monoallelic
isoforms are expressed.and control samples in different cell types. Using a 3-fold cutoff,
this analysis identified 18 genes consisting of alternative pro-
moters, in which their 50 ends were downregulated in the parthe-
nogenetic cells as compared with control cells (Table S5).
Among the 18 putative PEGs, 10 were uniquely expressed in
the NCAM1+ cells, and 5 were expressed exclusively in the
undifferentiated cells and the rest were downregulated in both
cell types (Table S5).
DISCUSSION
Recent advances in high-throughput genomic and transcrip-
tomic technologies have added only a few imprinted genes to
the previously known ones, suggesting that the vast majority of
imprinted genes have already been identified (Babak et al.,
2008; Choufani et al., 2011; Morcos et al., 2011; Pollard et al.,
2008). Nevertheless, recent genome-wide DNA methylation an-
alyses in mouse (Smallwood et al., 2011; Xie et al., 2012) and hu-
man (Choufani et al., 2011; Court et al., 2014; Stelzer et al., 2013)318 Cell Reports 11, 308–320, April 14, 2015 ª2015 The Authorsuncovered additional iDMRs, thus
implying that more imprinted genes
remain to be identified. One possible
explanation for this discrepancy is that
some of the genes, which are marked
with iDMR, are regulated in a monoallelic
fashion according to their tissue-specific
expression. Considering that most of the
research in the field was conducted only
on a small number of cell types, it is
possible that more genes remain to
be identified in other tissues. Indeed,
comparing the gene expression between
different parthenogenetic and control
cell types uncovered two candidate
PEGs (NAIP and WDR17) that are down-
regulated in the parthenogenetic cells
and expressed in a monoallelic fashion
in normal cells.
Surprisingly, in addition to the PEGs
that are consistently downregulated in
the parthenogenetic cells, we demon-
strated that nearly half of all known
PEGs are highly expressed in the parthe-
nogenetic cells, in comparable levels to
their expression in the control cells. Wefurther showed that the vast majority of these PEGs exhibited
both biallelic and imprinted monoallelic isoforms. Isoform-spe-
cific regulation was previously associated with some imprinted
genes (Hikichi et al., 2003; Kamei et al., 2007; Liu et al., 2005;
Wood et al., 2007); however, the magnitude of this phenomenon
was largely underappreciated. The simultaneous expression of
a biallelic and monoallelic isoforms at specific cell types
complicates the identification of the imprinted isoform (Figures
6A–6C). In most cases, the biallelic and monoallelic isoforms
differ in only a few exons (e.g., MEST; Figure 2D). Therefore,
only exon-based methods can distinguish between the different
isoforms. Similar to array and sequencing-based methods,
utilizing SNPs to identify monoallelic expression depends
heavily on the ratio of expression between the two isoforms
and is expected to show only minor parental bias in most of
these genes.
To overcome these limitations, we utilized two complementary
approaches to identify putative imprinted genes with alter-
native promoters: (1) a genome-wide search for iDMRs, taking
advantage of DNA methylation data from multiple published
cell lines, and (2) a technique identifying only the 50 mRNA
expression levels, which enabled us to distinguish appropriately
between the imprinted and non-imprinted transcripts. Analyzing
the 50 RNA sequencing results enabled a genome-wide identifi-
cation of differential expression between the parthenogenetic
and control cells but also within genes that are thought to consist
of a single TSS. We suggest that executing this method on
additional tissues and combining the results with appropriate
DNA methylation analysis will facilitate the identification of
additional, previously unidentified, isoform-specific imprinted
genes. Considering the specificity of the cell populations
included in our analysis, our findings support the notion that
dozens of tissue- and isoform-dependent imprinted genes
remain to be identified in human cells.
Finally, we show that the vast majority of the newly identified
iDMRs are also present in the chimpanzee, supporting their
evolutionary conservation. Interestingly, although genomic
imprinting was primarily and extensively studied in mouse,
recent data hint at differences between human and mouse
imprinted genes (Court et al., 2014; Nakabayashi et al., 2011;
Stelzer et al., 2011, 2013). Consistent with previous reports
(Court et al., 2014; Stelzer et al., 2013), nearly half of the
iDMRs identified in this study are not conserved between
mouse and human. Taken together, many of the recently
identified imprinted genes and iDMRs appear to be species
specific, strengthening the importance of studying parental
imprinting in human cells.EXPERIMENTAL PROCEDURES
Cell Types
Pg-iPSCs were established and cultured as previously described (Stelzer
et al., 2011). NCAM1-positive cells were derived from human PSCs using a
previously reported protocol for differentiation toward early NPCs (Kim et al.,
2010). CXCR4-positive cells were derived using a protocol for differentiation
toward early endodermal progenitor cells, as described in the Supplemental
Experimental Procedures. BMP4-treated cells were derived as previously
described (Stelzer et al., 2011).
Allelic Expression Analysis
Parent-of-origin allelic expression analysis was performed as previously
described (Morcos et al., 2011).
Genome-wide DMR Analysis
Themethylation analysis was performed using six independent whole-genome
bisulfite sequencing (WGBS) samples from different tissues, downloaded from
the NIH Roadmap Epigenomics Project (Bernstein et al., 2010), as described in
detail in Supplemental Experimental Procedures.
Generation and Analysis of 50 RNA Sequencing Libraries
50 RNA sequencing libraries were generated from undifferentiated and
NCAM1+ from both parthenogenetic and control cells. For more detailed
information regarding protocols and procedures, see Supplemental Experi-
mental Procedures.ACCESSION NUMBERS
The NCBI Gene Expression Omnibus accession number for the microarray
data reported in this paper is GEO: GSE65002.SUPPLEMENTAL INFORMATION
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three figures, and five tables and can be found with this article online at
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